SHMT2 and glioma: Furthermore, it has been reported that SHMT2 is highly expressed in glioma, intrahepatic cholangiocarcinoma, and hepatocellular carcinoma (12), reflecting that SHMT2 is partly involved in the process of tumorigenicity (10, 12, 13).